During the past decade, Sparks Regional Medical Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 11 clinical trials were completed, i.e. on average, 366.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sparks Regional Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 7 trials, followed by "Alexion" with 2 trials sponsored, "Duke University" with 2 trials sponsored, "PhotoThera, Inc" with 2 trials sponsored and "Spiration, Inc." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sparks Regional Medical Center" #1 collaborator was "Cancer and Leukemia Group B" with 3 trials as a collaborator, "Duke Clinical Research Institute" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator and "American College of Surgeons" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Sparks Regional Medical Center" are "Acute Myocardial Infarction" (2 trials), "Heart Failure" (2 trials), "Recurrent Breast Carcinoma" (2 trials), "Stage IIA Breast Cancer AJCC v6 and v7" (2 trials) and "Stage IIB Breast Cancer AJCC v6 and v7" (2 trials). Many other conditions were trialed in "Sparks Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Sparks Regional Medical Center" are "Drug" (15 trials), "Other" (8 trials), "Device" (5 trials), "Biological" (4 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (6 trials), "Placebo" (5 trials), "Quality-of-Life Assessment" (3 trials), "Bevacizumab" (2 trials) and "Letrozole" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sparks Regional Medical Center" are 21 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Sparks Regional Medical Center". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Sparks Regional Medical Center, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Sparks Regional Medical Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".